CAMBRIDGE, Mass., Oct. 12 /PRNewswire-FirstCall/ -- Verenium Corporation , a leading developer of cellulosic ethanol technology and a pioneer in the development of high-performance specialty enzymes, announced today that members of its management team will be presenting at three upcoming conferences.
Carlos A. Riva, Verenium's President and Chief Executive Officer, and William H. Baum, Verenium's Executive Vice President and General Manager, Specialty Enzymes Business Unit, will present next week at the Cellulosic Ethanol Summit. This event will bring high-level governmental, agricultural, financial, and commercial players together to stimulate the cross-industry business relationships that will be critical to making this new industry a reality. The Summit will be held from October 15 to 17 in Washington, D.C.
In addition, Mr. Baum and John A. McCarthy, Jr., Verenium's Executive Vice President and Chief Financial Officer, will present at the Platts Cellulosic Ethanol and 2nd Generation Biofuels Conference. This annual conference from Platts focuses on commercial viability and the business outlook for bringing advanced biofuels into industrial scale production. This event will be held from October 16 to 18 and will take place at the W Chicago City Center Hotel in Chicago.
Mr. Riva will also present at the Jefferies 4th Global Clean Technology Conference. The presentation is scheduled to begin at 1:20 p.m. (British Summer Time) on Thursday, October 18. More information about this event, including a live webcast, may be accessed by visiting the "Investors" section of Verenium's website at http://www.verenium.com/. A webcast replay will be available approximately one hour after the live webcast ends and will be accessible for one month following the conference.
About Verenium
Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. The Company possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.
Verenium's Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes-proteins that act as the catalysts of biochemical reactions.
Verenium recently completed a significant upgrade of one of the nation's first operational cellulosic ethanol pilot facilities located in Jennings, Louisiana and expects to achieve mechanical completion of a 1.4 million gallon-per-year, demonstration-scale facility to produce cellulosic ethanol by the end of the first quarter of 2008. In addition, the Company's process technology has been licensed by Tokyo-based Marubeni Corp. and Tsukishima Kikai Co., LTD and has been incorporated into BioEthanol Japan's 1.4 million liter-per-year cellulosic ethanol plant in Osaka, Japan -- the world's first commercial-scale plant to produce cellulosic ethanol from wood construction waste. For more information on Verenium, visit http://www.verenium.com/.
Forward-looking Statements
Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include statements related to the Company's operations, capabilities, commercialization activities, target markets and cellulosic ethanol facilities, all of which are prospective. Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's new and uncertain technologies, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, technological, regulatory, competitive and other risks related to development, production, and commercialization of cellulosic ethanol and other biofuels and the commercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercialized products, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the U.S. or global energy markets and risks and other uncertainties more fully described in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2007. These forward-looking statements speak only as of the date hereof. The Company expressly disclaims any intent or obligation to update these forward-looking statements.
Contacts:
Kelly Lindenboom Wendy Kelley
Vice President, Corporate Communications IR Specialist
617-674-5335 858-526-5437
